GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
32%
Guest openness
Selective
Sign up to generate a grounded pitch for GeneInCell.
Signup to Generate a PitchGeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing, tracking breakthroughs from bench to bedside for better human health, including Biotech and business.
GeneInCell is hosted by Vinod Reddy Lekkala. The show has published 42 episodes to date.
Recent episodes include "Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with Light | GeneInCell | 2026" (11 October 2026, 51 minutes), "Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with Light | GeneInCell | 2026" (11 October 2026, 51 minutes), and "AlphaGenome: Finding Disease in the Dark Genome | GeneInCell | 2026" (13 September 2026, 45 minutes).
GeneInCell publishes roughly every two weeks, with episodes averaging 55 minutes across 42 episodes.
Booking probability for GeneInCell is 32%, and the host is rated Selective on guests. GeneInCell requires a Pod Score of 80 or higher. GeneInCell's contact route on record: verified email.
The strongest fits for GeneInCell are Scientific Research & Development. GeneInCell has a science audience.
Vinod Reddy Lekkala hosts GeneInCell, a science podcast with 42 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #21
<p>Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize in Physiology or Medicine, how...
Episode #21
Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize in Physiology or Medicine, how...
<p>AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin accessibility, and gene regulation, it...
AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin accessibility, and gene regulation, it can...
<p>Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune cells, and why...
Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune cells, and why...
<p>Can peptides help slow the biological processes of aging? In this episode, we explore how anti-aging peptides may influence cellular repair, inflammation, metabolism, collagen production, and tissue regeneration. We...
<p>Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating telomerase could slow age-related decline...
Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating telomerase could slow age-related decline...
<p>Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this episode, we explore...
Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this episode, we explore how...
<p>Aptamers are emerging as powerful “chemical antibodies” that can bind targets with high precision while offering advantages in design, synthesis, and stability. In this episode, we explore how these short nucleic...
<p>Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to reduce harmful...
<p>shRNA is a gene-silencing tool that uses the cell’s own RNA interference machinery to reduce harmful protein production. In this episode, we explore how short hairpin RNAs are designed to target specific mutant...
<p>Base editing is changing the future of gene editing by allowing scientists to rewrite DNA one letter at a time. In this episode, we explore how base editors work, why they offer a more precise alternative to...
<p>siRNAs are transforming medicine by acting as programmable drugs that selectively silence disease-causing genes. In this episode, we explore how small interfering RNAs work through the RNA interference pathway, why...
<p>Prime editing is a next-generation gene editing tool designed to precisely rewrite DNA—like a search-and-replace function for the human genome. In this episode, we break down how prime editing works, the chemistry...
Episode #9
<p>NAMs are changing how new drugs are developed. We discuss organoids, tissue chips, and AI-based tools, along with the growing FDA and NIH push toward more human-relevant methods that can improve prediction, reduce...
<p>Can we grow new kidneys from stem cells? In this episode, we explore how scientists are using pluripotent stem cells to create kidney organoids that mimic early kidney development. We discuss how these mini-organs...
<p>What really happens to your cells under stress, in space, and during space travel? In this episode, we zoom in on the physiological, cellular, and molecular levels to uncover how zero gravity affects them.</p>
PitchCentric classifies GeneInCell under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
